1018443-01-0

Basic information

• Product Name: 3-(BOC-AMINO)-3-METHYLAZETIDINE
• Synonyms: 3-(BOC-AMINO)-3-METHYLAZETIDINE;3-(Boc-aMino)-3-Methylaze...;tert-Butyl (3-methylazetidin-3-yl)carbamate;(3-Methyl-azetidin-3-yl)-carbamic acid tert-butyl ester
• CAS NO: 1018443-01-0
• Molecular Formula: C₉H₁₈N₂O₂
• Molecular Weight: 186.25142
• Mol File: 1018443-01-0.mol

Chemical Properties

• Boiling Point: 270.6±29.0 °C(Predicted)
• Appearance: /
• Density: 1.04±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 10.26±0.20(Predicted)
• CAS DataBase Reference: 3-(BOC-AMINO)-3-METHYLAZETIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(BOC-AMINO)-3-METHYLAZETIDINE(1018443-01-0)
• EPA Substance Registry System: 3-(BOC-AMINO)-3-METHYLAZETIDINE(1018443-01-0)

Safety Data

• Hazardous Substances Data: 1018443-01-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
3-(BOC-AMINO)-3-METHYLAZETIDINE is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and BOC-protected amine group contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, 3-(BOC-AMINO)-3-METHYLAZETIDINE is utilized as a key component in the synthesis of compounds designed to protect crops and enhance agricultural productivity. Its structural features make it a valuable asset in creating effective and targeted agrochemicals.
Used as a Reagent in Organic Chemistry:
3-(BOC-AMINO)-3-METHYLAZETIDINE also serves as a reagent in organic chemistry reactions. Its distinctive structural elements allow it to participate in a variety of chemical processes, facilitating the synthesis of complex organic molecules for research and industrial applications.

Upstream product

• 920320-54-3 (1-benzhydryl-3-methyl-azetidin-3-yl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Melanin Concentrating Hormone Receptor-1 Antagonist Pyridinones

The present invention provides for MCHR1 antagonist compounds of formula (I) and the pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein the substituents are as defined herein, and the pharmaceutically acceptable salts, solvates and

ANTAGONISTS OF SNS SODIUM CHANNELS

Compounds of the formula (I), and pharmaceutically acceptable salts thereof, are found to be antagonists of SNS sodium channels. They are therefore useful as analgesic and neuroprotective agents, formula (I): R1 represents: (a) -L-A or -L' -A'